ARCHIVES

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 35 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Nixon to Receive ACCC Annual Award

January 10, 1986

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

June 28, 2013

Two Private Cancer Information Services Are Up and Running

May 13, 1988

Constance Percy Retires From NCI After 30 Years.

November 10, 2000

Avastin Improves PFS Compared To Chemo Alone

January 29, 2010

NCI Bypass Budget Seeks $3.6 Billion for Fiscal 1995

October 1, 1993